@Grainofsand, welcome aboard eventually. Once you are in, I would be most grateful if you could explain why you invested.
Thanks @kpax - I squared my holding away today. My main reasons for investing in SNT, in no particular order, include:
- 1 year cash runway
- 3 or 4 different Phase 2 trial results all due by mid-2025
- Positive data from SNT 5505 monotherapy study! It's interim Ph2 data is due in Dec '24
- SNT 5505 - demonstrated reduction in bone marrow fibrosis AND demonstrated improvement in scar appearance
- Company has worked with Fiona Wood for 5 years on scar treatment. There are no other pharma treatments in development and Fiona Wood saw the full inhibition of L enzymes, and the 30% reduction of collagen in scars, over only a 3-month period, as UNPRECEDENTED! Trial patients still continue to improve after the end of the trial.
- Management have taken serious steps to reduce costs and stretch funds
- $10m raised late last year from institutions at 2.2c. Platinum Investments increasing their holding from 8-20%. As a friend of mine said - these institutions employ people to do due diligence on their investments - if an investment is good enough for them, then it's good enough for me!
- I haven't checked but CEO advises of a super strong register of investors with 60% being instos
- Focus by company - cancer of the blood and skin scarring
- Huge potential market for just one of these products, let alone more than one. I think market exposure for all was something like $15b!
- Some people, who I value as knowing a lot more about bios than myself, think SNT is an exceptional buying opportunity! Works for me!
- Forums
- ASX - By Stock
- SNT
- SNT JustStocks Video on YouTube
SNT JustStocks Video on YouTube, page-36
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.002(9.09%) |
Mkt cap ! $28.65M |
Open | High | Low | Value | Volume |
2.2¢ | 2.5¢ | 2.2¢ | $12.04K | 509.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 82668 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 82668 | 0.023 |
2 | 338839 | 0.022 |
5 | 1736248 | 0.021 |
11 | 2801008 | 0.020 |
2 | 999988 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 100000 | 1 |
0.025 | 100000 | 1 |
0.026 | 50000 | 1 |
0.027 | 200000 | 1 |
0.028 | 500000 | 1 |
Last trade - 15.57pm 28/06/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online